INTCO MEDICAL(SZ:300677) Sou Hu Cai Jing·2026-02-03 12:37Core Viewpoint - The stock of Yingke Medical (300677) has shown a slight increase, with a closing price of 40.55 yuan on February 3, 2026, reflecting a 1.38% rise, amidst mixed capital flows from different investor types [1]. Group 1: Stock Performance and Capital Flow - On February 3, 2026, the stock recorded a trading volume of 61,800 hands and a total transaction amount of 250 million yuan [1]. - The net inflow of main funds was 4.6573 million yuan, accounting for 1.86% of the total transaction amount, while retail investors experienced a net outflow of 8.2815 million yuan, representing 3.31% of the total [1][2]. - Over the past five days, the stock has seen fluctuations in capital flow, with significant net inflows and outflows from both main and retail investors [2]. Group 2: Financial Metrics and Industry Ranking - Yingke Medical has a total market value of 26.567 billion yuan, ranking 8th in the medical device industry, which has an average market value of 10.943 billion yuan [3]. - The company reported a net profit of 924 million yuan, which is 34.47% higher year-on-year, while its main revenue for the first three quarters of 2025 was 7.425 billion yuan, up 4.6% year-on-year [3]. - The company's gross profit margin stands at 23.7%, significantly lower than the industry average of 50.55%, indicating potential areas for improvement [3]. Group 3: Analyst Ratings - In the last 90 days, six institutions have provided ratings for Yingke Medical, with five giving a "buy" rating and one an "accumulate" rating, reflecting a generally positive outlook from analysts [4].